Pressure Biosciences Inc Com (NASDAQ:PBIO)

CAPS Rating: No stars

The Company is engaged in the research, development and commercialization of products utilizing its patented pressure cycling technology, a novel platform technology for the control of bio-molecular interactions.

No one has written a Pitch for PBIO yet. Tell us why you think PBIO will outperform or underperform the market.

Featured Broker Partners